PF-06821497
PF-06821497 Uses, Dosage, Side Effects, Food Interaction and all others data.
PF-06821497 is under investigation in clinical trial NCT03460977 (PF-06821497 Treatment Of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma).
Trade Name | PF-06821497 |
Generic | PF-06821497 |
Type | |
Formula | C22H24Cl2N2O5 |
Weight | Average: 467.34 Monoisotopic: 466.1062273 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Innovators Monograph
You find simplified version here PF-06821497